Pharmacological Characterization of the Allosteric Modulator Desformylflustrabromine and Its Interaction with α4β2 Neuronal Nicotinic Acetylcholine Receptor Orthosteric Ligands

Por Weltzin, Maegan M., Schulte, Marvin K.
Publicado em 2010

Desformylflustrabromine Modulates α4β2 Neuronal Nicotinic Acetylcholine Receptor High- and Low-Sensitivity Isoforms at Allosteric Clefts Containing the β2 Subunit

Por Weltzin, Maegan M., Schulte, Marvin K.
Publicado no J Pharmacol Exp Ther (2015)

Allosteric modulation of alpha4beta2 nicotinic acetylcholine receptors by HEPES()

Por Weltzin, Maegan M, Huang, Yanzhou, Schulte, Marvin K
Publicado em 2012

Distinctive effects of nicotinic receptor intracellular-loop mutations associated with nocturnal frontal lobe epilepsy

Por Weltzin, Maegan M., Lindstrom, Jon M., Lukas, Ronald J., Whiteaker, Paul
Publicado no Neuropharmacology (2015)

Differential α4(+)/(−)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms

Por Lucero, Linda M., Weltzin, Maegan M., Eaton, J. Brek, Cooper, John F., Lindstrom, Jon M., Lukas, Ronald J., Whiteaker, Paul
Publicado no J Biol Chem (2016)

A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors

Por Luo, Sulan, Zhangsun, Dongting, Schroeder, Christina I., Zhu, Xiaopeng, Hu, Yuanyan, Wu, Yong, Weltzin, Maegan M., Eberhard, Spencer, Kaas, Quentin, Craik, David J., McIntosh, J. Michael, Whiteaker, Paul
Publicado em 2014